Corey, G. R., Loutit, J., Moeck, G., Wikler, M., Dudley, M. N., & O'Riordan, W. (2018). Single Intravenous Dose of Oritavancin for Treatment of Acute Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: Summary of Safety Analysis from the Phase 3 SOLO Studies. Antimicrob Agents Chemother.

Corey, G. Ralph, Jeffery Loutit, Greg Moeck, Matthew Wikler, Michael N. Dudley, και William O'Riordan. "Single Intravenous Dose of Oritavancin for Treatment of Acute Skin and Skin Structure Infections Caused By Gram-Positive Bacteria: Summary of Safety Analysis From the Phase 3 SOLO Studies." Antimicrob Agents Chemother 2018.

Corey, G. Ralph, et al. "Single Intravenous Dose of Oritavancin for Treatment of Acute Skin and Skin Structure Infections Caused By Gram-Positive Bacteria: Summary of Safety Analysis From the Phase 3 SOLO Studies." Antimicrob Agents Chemother 2018.